Stryker to add rotator cuff repair tech with ZuriMED buy
Rotator cuff augmentation is one of the fastest-growing areas in sports medicine, according to Stryker.
Stryker to add rotator cuff repair tech with ZuriMED buy Read More »
Rotator cuff augmentation is one of the fastest-growing areas in sports medicine, according to Stryker.
Stryker to add rotator cuff repair tech with ZuriMED buy Read More »
An analysis of more than 550 million healthcare encounters from the EHR giant’s research division illuminates how restricting Medicaid coverage leaves low-income patients more directly on the hook for medical bills.
Medicaid losses leave more patients paying cash, Epic finds Read More »
Focused on Medicaid, the new pacts now involve more than just large pharmaceutical companies.
Mid-cap biotechs join Trump’s latest round of drug pricing deals Read More »
El contexto digital actual progresa a un ritmo acelerado, lo que incrementa las brechas de seguridad para que los ciberdelincuentes puedan ejecutar sus ataques. Ante esta situación, las empresas no quieren continuar con una actitud reactiva ante los incidentes informáticos. …
Roche has tapped Simcere Zaiming for a new T cell engager that could have broad application in B cell–mediated diseases including lymphoma and autoimmune conditions.
Roche finds another oncology gem in Asia with $1.5B B cell disease partnership Read More »
The diabetes tech firm is preparing for the launch of new devices, including a tubeless insulin pump and a fully closed loop automated insulin delivery system.
MiniMed submits new patch pump for FDA clearance Read More »
The medical device maker grew revenue by double digits in its fiscal first quarter, following fourth-quarter growth of nearly 10%.
Medtronic kicks off its fiscal year on a high note Read More »
GSK’s vaccine—which targets two primary flu antigens—elicited higher immune responses in both younger and older adults in a mid-stage study. The Phase 3 launch, planned for September, follows the FDA’s recent approval for Moderna’s mRNA flu vaccine.
GSK to launch Phase 3 trial for mRNA-based flu vaccine amid resurgence for the modality Read More »
The systems agreed to 10 years of state oversight and $600 million in investments as South Dakota-based Sanford moves into the Twin Cities.
Sanford-North Memorial deal closes after systems ink oversight agreement Read More »
The certification positions GE HealthCare to challenge Siemens Healthineers for the European market.
GE HealthCare secures CE mark for photon-counting CT device Read More »